3 ms·
TL;DR: "Based on our study, we propose that type I IFN deficiency is a hallmark of severe COVID-19 and infer that severe COVID-19 patients might be potentially
by 1MachineElf 6y ago
TL;DR:
"Based on our study, we propose that type I IFN deficiency is a hallmark of severe COVID-19 and infer that severe COVID-19 patients might be potentially relieved from the IFN deficiency by IFN administration and from exacerbated inflammation by adapted anti-inflammatory therapies targeting IL-6 or TNF-α, a hypothesis worth cautious testing."
- lymeeducator 6y agoPerhaps enjoy some turmeric to lower IL-6, which is widely used to positive effect in many non-pharma regimens and is also complimentary with some pharma. https://pubmed.ncbi.nlm.nih.gov/27719643/ https://pubmed.ncbi.nlm.nih.gov/27719643/